ストックスクリーナーアプリを入手
0.6356
2.22%
-0.0144
アフターアワーズ：
.64
0.0044
+0.69%
Standard Biotools Inc (LAB) 最新ニュース
LAB 8-K & SEC Filings - Yahoo! Finance Canada
A 1-for-20 to 1-for-40 reverse split is proposed as Standard BioTools (LAB) plans its Treeline merger. - Stock Titan
A healthcare-focused investor agrees to buy Microfluidics from Standard BioTools (LAB). - Stock Titan
A conditional sale expected to close in about 30 days would move Microfluidics out of Standard BioTools (LAB). - Stock Titan
Standard BioTools Finalizes $5.5M Mass Cytometry Business Sale to Element Biosystems - Kalkine Media
Standard BioTools Provides Update on Sale of Mass Cytometry Business - The Manila Times
Standard BioTools Inc.Common Stock (Nasdaq:LAB) Detailed Stock Data - The Chronicle-Journal
Are SMTI, LAB, ATKR, VAL Obtaining Fair Deals for their Shareholders? - Morningstar
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Proxy and Looming Shareholder Merger Vote --VRME, VAL, LAB and FTHM - PR Newswire
Treeline deal leaves Standard BioTools (NASDAQ: LAB) investors with a minority stake - Stock Titan
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger—IRDM, VRME, VAL and LAB - GlobeNewswire Inc.
INVESTOR ALERT: The M&A Class Action Firm Launches Investigation of the Merger--IRDM, VRME, VAL and LAB - Lelezard
Standard BioTools And 2 Other Promising Penny Stocks For Your Watchlist - simplywall.st
Standard BioTools (LAB) Slips 1.24% to $0.65 as Tight Trading Range Takes ShapeTriple MA Cross - dars.gov.et
Standard Biotools Inc (LAB) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Standard BioTools (LAB) CEO uses 97K shares to pay taxes - Stock Titan
Standard BioTools (NASDAQ: LAB) exec uses 25.7K shares for taxes - Stock Titan
Standard BioTools (LAB) CFO sees stock withheld for taxes - Stock Titan
Standard (LAB) Session: Moves 0.73% Up to $0.65; Next Session: the Near-Term Reference Band Stretches From $0.62 to $0.68 under the Current SnapshotSentiment Shift - vinanet.vn
Enterprise value to EBIT forward of Standard BioTools Inc. – BX:FLB - TradingView
Long Focus Capital Management, LLC Adds to Standard BioTools Inc - GuruFocus
Standard BioTools (LAB) Slides 4.99% to $0.71 as Selling Pressure PersistsFactor Valuation - vinanet.vn
Standard BioTools (LAB) Slides 4.99% to $0.71 as Selling Pressure PersistsInstitutional Volume - dars.gov.et
Standard BioTools Inc (LAB) Fundamental & Financial Data - Stocktwits
Standard BioTools (LAB) holders report 7.3% stake in amended ownership filing - Stock Titan
Standard BioTools Inc.: Target Price Consensus and Analysts Recommendations | LAB | US34385P1084 - marketscreener.com
Standard BioTools Inc (LAB) sentiment score, message volume, participation score and buzz level - Stocktwits
LAB: Standard BioTools Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Standard BioTools (LAB): Long Focus Capital discloses 23.5M shares, 6% passive stake - Stock Titan
Standard BioTools (LAB) Short Interest & Short Float | Updated Aug 2026 $LAB - MarketBeat
Standard BioTools Inc (LAB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Standard BioTools Inc (LAB) Stock News Today - TradingKey
Standard BioTools Inc (LAB) Stock News Today - TradingKey
Is Standard BioTools Inc (LAB) Overvalued After Q2 Loss? EPS: -$0.21, Revenue: $20.1M -- GF Score: 33/100 - GuruFocus
Standard BioTools Inc. (LAB) Stock Report: Evaluating a Potential 93% Upside in the Medical Devices Sector - DirectorsTalk Interviews
Standard BioTools (LAB) Holds Steady at $0.80: Consolidation or Pivot Point Ahead?Growth Stock Picks - dars.gov.et
Standard BioTools (NasdaqGS:LAB) Stock Forecast & Analyst Predictions - Simply Wall Street
BlackRock, Inc. Reduces Standard BioTools Inc (LAB) Stake -- Sha - GuruFocus
Standard BioTools Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Standard BioTools (NASDAQ:LAB) Issues Earnings Results - MarketBeat
Standard BioTools Q2 2026 Earnings: Cost Cuts Narrow the Adjusted EBITDA Loss - TradingKey
Standard BioTools Q2 revenue falls on consumables weakness - TradingView
STANDARD BIOTOOLS ($LAB) Releases Q2 2026 Earnings - Quiver Quantitative
STANDARD BIOTOOLS INC. Q2 2026: Revenue $20.1M, EPS $(0.07) — 10-Q Summary - TradingView
Standard BioTools: Q2 Earnings Snapshot - barchart.com
Standard BioTools (NASDAQ: LAB) Q2 revenue $20.1M as merger advances - Stock Titan
Standard BioTools Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Standard BioTools Reports Second Quarter 2026 Financial Results - The Manila Times
BRIEF-Standard BioTools Q2 EPS USD -0.07 - TradingView
Standard Biotools Inc. Withdraws Earnings Guidance for the Full Year 2026 - marketscreener.com
6.50%
3.38%
大文字化:
|
ボリューム (24 時間):